Iovance Biotherapeutics Inc (NAS:IOVA)
$ 9.32 -0.08 (-0.85%) Market Cap: 2.84 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 3.67 GF Score: 39/100

Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference Transcript

Mar 17, 2022 / 02:45PM GMT
Release Date Price: $14.67 (+9.56%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

So first and foremost for us at Barclays down in Miami, this is our last session for the conference. So thank you for everyone for attending and making this live event happen and for everyone who's been enthusiastic or the questions or the participation or your time, so much appreciated. It's the first event in a couple of years, and it feels like we're getting back to normal, which is fantastic.

Jean;Marc Bellemin
Iovance Biotherapeutics, Inc. - CFO & Principal Accounting Officer

So good to be in person.

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Yes. Yes, exactly. So my name is Peter Lawson, and I'm the biotech analyst, or one of the biotech analysts at Barclays. I cover -- have the pleasure of covering our events. So up on the stage, I've got Jean-Marc Bellemin, CFO; and Madan Jagasia, SVP of Medical Affairs. We had dinner last night and that went very well, and I'm sure there's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot